I. Reindl

Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study

U. Steinseifer, K. Werdan, A. Schlitt, 2011, Journal of Thrombosis and Thrombolysis.

Are the elderly different?

K. Werdan, A. Schlitt, M. Buerke, 2013, Zeitschrift für Gerontologie und Geriatrie.

[Cardiac biomarkers in perioperative medicine : significance for noncardiac surgery patients].

K. Werdan, A. Schlitt, M. Buerke, 2011, Der Anaesthesist.

Treatment Options in Acute Coronary Syndromes: Focus on Fondaparinux Sodium

A. Schlitt, I. Reindl, 2010 .

In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus

K. Werdan, A. Schlitt, H. Rupprecht, 2008, Coronary artery disease.

Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis

K. Werdan, A. Schlitt, M. Buerke, 2008, Thrombosis and Haemostasis.

Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients.

N. Lambrecht, M. Fleischhacker, B. Schmidt, 2017, Clinica chimica acta; international journal of clinical chemistry.

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting

K. Werdan, A. Schlitt, M. Buerke, 2011, Vascular health and risk management.